Mantle Cell Lymphoma

Last week at the 54th American Society of Hematology Annual Meeting and Exposition in Atlanta,

Mantle cell lymphoma (MCL) is a rare type of B-Cell lymphoma. It

Mantle cell lymphoma (MCL) is a relatively rare

The U.S. Food and Drug Administration today has approved Imbruvica (ibrutinib) for the

The Leukemia and Lymphoma Society, the largest charity in the world dedicated to blood

Changing R-CHOP improved outcomes in patients with mantle cell lymphoma (MCL), according

According to the manufacturer, Velcade (bortezomib) has been approved by the US FDA in

For one month in the March 2010 issue of the journal Leukemia & Lymphoma, members

The Committee for Medicinal Products for Human Use of the European Medicines Agency has

The FDA has made two significant changes to the dosage and safety information for the

The European Commission approved the drug Velcade (bortezomib) for the treatment of

Next up in the Leukemia & Lymphoma Society's free telephone/web education programs

Sitemap